CA-MARY-KAY
24.2.2021 14:36:06 CET | Business Wire | Press release
Glamhive announced its fourth online conference to be held on February 27, 2021. The Glamhive Digital Winter Style and Beauty Summit will bring together top fashion and beauty leaders, from Kristen Bell's stylist to billion-dollar founder-turned female founder investor Cindy Eckert. The innovative leaders will discuss fashion, beauty, entrepreneurship, and more. Stephanie Sprangers and Nicole Chavez will co-host the event.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005275/en/
"I have loved being part of Glamhive's style & beauty summits, particularly during this challenging time. The summits have brought a sense of community, which is lacking in the world of creative talent, plus I have made some amazing connections with other artists along the way," said Nicole Chavez, celebrity stylist. Nicole is one of the most in-demand stylists today. Her clientele has ranged from A-List stars Kristen Bell, Rachel Bilson, Jessica Simpson, Ellie Bamber, Scarlett Johansson, Catherine Zeta-Jones, and many more. Her work has been featured in many publications, including W, InStyle, and Harper's Bazaar.
"Glamhive's vision is to give the benefits of working with a personal stylist available to everyone, everywhere, and our digital events are a wonderful extension of that. The silver lining of the past year is that it enabled us to pivot our style summits to digital, thereby making it possible for everyone, everywhere to meet and learn from the best in the business," said Stephanie Sprangers, Glamhive Founder and CEO. Sprangers is the Founder and Chief Executive Officer of Glamhive, the online personal styling service that brings expert personal stylists and makeup artists—recruited directly from Hollywood and Instagram—to everyone. Glamhive has developed proprietary software that allows stylists to take clients through a styling experience that is 100% online, allowing people to work with stylists anywhere in the world.
The all-day, ticketed event will feature over 60 speakers. Below is an overview of some of the topics that this all-star speaker line-up will cover.
TOPICS SNAPSHOT:
The day will consist of 22 segments across two-tracks. A snapshot:
- Red Carpet Style: Creating Iconic Style Moments
- 2021 Trends: Post-Pandemic Style
- Winning the Style Game: Vintage is Your Secret Weapon
- The Stylists Playbook: How to Get the Best Style of Your Life
- Beauty Boss Babe: An Interview with Jamie Kern Lima
- The Ultimate Guide to "Easy" Hair
- Let's Get Social: The Best Instagram and TikTok Beauty Trends
- The Astrology of Fashion: With Susan Miller
- More Than Meets the Eye: What Your Clothes Say About You
- The ROI of Style: How Dressing Well Pays Off
- How I Built This: Darn Good Advice from Women Who Made It to the Top
SPEAKERS:
Speakers include celebrity stylists, makeup artists, image-makers who work with the biggest names in Hollywood and beyond, including:
Angelina Jolie, Serena Williams, Mandy Moore, Sarah Jessica Parker, Kristen Bell, Khloe Kardashian, Robert Downey Jr., Keanu Reeves, Sharon Stone, Serena Williams, Miranda Lambert, Julianne Moore, and more.
CELEBRITY STYLISTS:
Nicole Chavez, Jill + Jordan, Jeanne Yang, Jennifer Rade, Tara Swennen, Janelle Miller, Lindsey Dupuis, Tiffany Gifford, Kesha McLoud, and Sonia Young.
CELEBRITY MAKEUP ARTISTS + HAIRSTYLISTS:
Tommy Buckett, Todd Harris, Diana Madison, Danny Moon, AJ Crimson, and Helen Reavey.
ENTREPRENEURS, DESIGNERS, AND BUSINESS LEADERS:
Claire Sulmers (Fashion Bomb Daily), Hillary Kerr (WhoWhatWear), Tara Rudes Dann (L'Agence), Steven Dann (Designer), Cindy Eckert (The Pink Ceiling Fund), Helen Ravey (Act+Acre), Cassandra Cadwell (Violet Grey), Michelle Waugh (Designer), Clarissa Egana (Port De Bras), Amy Rosoff Davis (Celebrity Trainer), Jamie Kern Lima (IT Cosmetics).
MODERATORS:
Brian Underwood (O Magazine), Brooke Jaffe (Penske Media), Pandora Amoratis (Daily Mail), Andrea Lavanthal (PEOPLE), Robin Nazzaro (O Magazine), Alexis Bennett (Vogue) and Kibwe Chase-Marshall (The Kelly Initiative).
Tickets to the conference are $149 for an all-day ticket. The Glamhive Digital Winter Style and Beauty Summit's presenting sponsor is Mary Kay Inc. and its Mary Kay Global Design Studio.
For more information, visit www.glamhive.com/upcoming .
About Glamhive
Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous.
The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. The Glamhive platform is a seamless end-to-end platform for stylists to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 57 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom